Bayer Yakuhin Transfers Fludara Rights To Genzyme Japan
This article was originally published in PharmAsia News
Executive SummaryBayer Yakuhin signed an agreement to transfer Fludara (fludarabine) rights to Genzyme Japan starting July 1
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.